ArticleDisease markers2022

Partial-Methylated HeyL Promoter Predicts the Severe Illness in Egyptian COVID-19 Patients.

Hewida H Fadel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.